Lisata Therapeutics Acquires Marea Therapeutics; Announces Concurrent Private Placement
(RTTNews) - Lisata Therapeutics (LSTA) has acquired Marea Therapeutics, a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop next-generation medicines for cardioendocrine diseases. The acquisition was structured as a stock-for-stock t
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.